维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Cheung TW"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix显示文摘	Leung TW Xue WC Cheung ANY	2004	Gynecol Oncol2004，92，3：	1
2	Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations显示文摘	Mak TW Cheung CK Cheung CM	1997	Nephrol Dial Transplant1997，12，1：	1
3	Diagnosing acute appendi- citis: are we overusing radiologic investigations 显示文摘	Wong KK Cheung TW Tam PK	2008	J Pediatr Surg2008，43，：	1
4	Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
5	Induction ofdrug resistance and transformation in human cancer cellsby the noncoding RNA CUDR 显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
6	Diagnosing acute appendicitis:are we overusing radiologic investigations?显示文摘	Wong KK Cheung TW Tam PK	2008	J Pediatr Surg2008，43，12：	1
7	An international comparison of childhood injuries in Hong Kong显示文摘	Chan CC Cheung JC Wong TW	2000	Injury Prevention2000，，01：	1
8	Induction of drug resistance and transformation in human cancer ceils by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
9	Induction of drug resistance and transformation in human cancer cells by the noncoding RNACUDR 显示文摘	TSANG WP WONG TW CHEUNG AH	2007	RNA2007，13，6：	1
10	Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CU- DR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
11	Induction of drug re- sistance and transformation in human cancer ceils by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	Rna2007，13，6：	1
12	Induction of drug re- sistance and transformation in human cancer cells by the noncod- ingRNACUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
13	Proliferation to apoptosis ratio as a prognostic marker in adenocarcinoma of uterine cervix显示文摘	Leung TW Xue WC Cheung AN	2004	Gynecol Oncol2004，92，3：	1
14	Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
15	AIDS-related cancer in the era of highly active antiretronral therapy (HAART) : a model of the interphy of the immune system, virus, and cancer 显示文摘	Cheung TW	2004	Cancer Invest2004，22，5：	1
16	Upfront consolidation treatment with 131I-mIBG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma显示文摘Importance:131I-metaiodobenzylguanidine(131I-mIBG)has a significant targeted antitumor effect for neuroblastoma.However,currently there is a paucity of data for the use of 131I-mIBG as a'front-line'therapeutic agent in those patients with newly diagnosed high-risk neuroblastoma as part of the conditioning regimen for myeloablative chemotherapy(MAC).Objective:To evaluate the feasibility of upfront consolidation treatment with 131I-mIBG plus MAC and hematopoietic stem cell transplantation(HSCT)in high-risk neuroblastoma patients.Methods:A retrospective,single-center study was conducted from 2003-2019 on newly diagnosed high-risk neuroblastoma patients without progressive disease(PD)after the completion of induction therapy.They received 131I-mIBG infusion and MAC followed by HSCT.Results:A total of 24 high-risk neuroblastoma patients were enrolled with a median age of 3.0 years at diagnosis.After receiving this sequential consolidation treatment,3 of 13 patients who were in partial response(PR)before 131I-mIBG treatment achieved either complete response(CR)(n=1)or very good partial response(VGPR)(n=2)after HSCT.With a median follow-up duration of 13.0 months after 131I-mIBG therapy,the 5-year event-free survival and overall survival rates estimated were 29%and 38%for the entire cohort,and 53%and 67%for the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Interpretation:Upfront consolidation treatment with 131I-mIBG plus MAC and HSCT is feasible and tolerable in high-risk neuroblastoma patients,however the survival benefit of this 131I-mIBG regimen is only observed in the patients who were in CR/VGPR at the time of 131I-mIBG treatment.	Jianhua Feng Frankie WT Cheng Alex WK Leung Vincent Lee Eva WM Yeung Hoi Ching Lam Jeanny Cheung Grace KS Lam Terry TW Chow Carol LS Yan Chi Kong Li	2020	Pediatric Investigation2020，4，3：	1
17	A bone graft condensing syringe for maxillofacial reconstructive surgery显示文摘	Cheung LK Samman N Chow TW	1997	Bri J Oral Maxillofac Surg1997，35，4：	1
18	Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	Rna2007，13，6：	1
19	Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR显示文摘	Tsang WP Wong TW Cheung AH	2007	RNA2007，13，6：	1
20	PTEN in the haematopoietic system and its therapeutic indications 显示文摘	Cheung AM Mak TW	2006	Trends Mol Med2006，12，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示